318 related articles for article (PubMed ID: 14566051)
1. Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome.
Richards A; Kemp EJ; Liszewski MK; Goodship JA; Lampe AK; Decorte R; Müslümanoğlu MH; Kavukcu S; Filler G; Pirson Y; Wen LS; Atkinson JP; Goodship TH
Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12966-71. PubMed ID: 14566051
[TBL] [Abstract][Full Text] [Related]
2. Modeling how CD46 deficiency predisposes to atypical hemolytic uremic syndrome.
Liszewski MK; Leung MK; Schraml B; Goodship TH; Atkinson JP
Mol Immunol; 2007 Mar; 44(7):1559-68. PubMed ID: 17027083
[TBL] [Abstract][Full Text] [Related]
3. Mutations in CD46, a complement regulatory protein, predispose to atypical HUS.
Goodship TH; Liszewski MK; Kemp EJ; Richards A; Atkinson JP
Trends Mol Med; 2004 May; 10(5):226-31. PubMed ID: 15121049
[TBL] [Abstract][Full Text] [Related]
4. Familial haemolytic uraemic syndrome and an MCP mutation.
Noris M; Brioschi S; Caprioli J; Todeschini M; Bresin E; Porrati F; Gamba S; Remuzzi G;
Lancet; 2003 Nov; 362(9395):1542-7. PubMed ID: 14615110
[TBL] [Abstract][Full Text] [Related]
5. Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndrome.
Richards A; Kathryn Liszewski M; Kavanagh D; Fang CJ; Moulton E; Fremeaux-Bacchi V; Remuzzi G; Noris M; Goodship TH; Atkinson JP
Mol Immunol; 2007 Jan; 44(1-3):111-22. PubMed ID: 16882452
[TBL] [Abstract][Full Text] [Related]
6. Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome.
Fremeaux-Bacchi V; Moulton EA; Kavanagh D; Dragon-Durey MA; Blouin J; Caudy A; Arzouk N; Cleper R; Francois M; Guest G; Pourrat J; Seligman R; Fridman WH; Loirat C; Atkinson JP
J Am Soc Nephrol; 2006 Jul; 17(7):2017-25. PubMed ID: 16762990
[TBL] [Abstract][Full Text] [Related]
7. Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome.
Kavanagh D; Kemp EJ; Mayland E; Winney RJ; Duffield JS; Warwick G; Richards A; Ward R; Goodship JA; Goodship TH
J Am Soc Nephrol; 2005 Jul; 16(7):2150-5. PubMed ID: 15917334
[TBL] [Abstract][Full Text] [Related]
8. Role of membrane cofactor protein (CD46) in regulation of C4b and C3b deposited on cells.
Barilla-LaBarca ML; Liszewski MK; Lambris JD; Hourcade D; Atkinson JP
J Immunol; 2002 Jun; 168(12):6298-304. PubMed ID: 12055245
[TBL] [Abstract][Full Text] [Related]
9. Inherited dysregulation of the complement system.
Goodship T
Bull Mem Acad R Med Belg; 2004; 159(Pt 2):195-8. PubMed ID: 15615093
[TBL] [Abstract][Full Text] [Related]
10. Membrane cofactor protein (MCP; CD46). Isoforms differ in protection against the classical pathway of complement.
Liszewski MK; Atkinson JP
J Immunol; 1996 Jun; 156(11):4415-21. PubMed ID: 8666815
[TBL] [Abstract][Full Text] [Related]
11. Diversity of sites for measles virus binding and for inactivation of complement C3b and C4b on membrane cofactor protein CD46.
Iwata K; Seya T; Yanagi Y; Pesando JM; Johnson PM; Okabe M; Ueda S; Ariga H; Nagasawa S
J Biol Chem; 1995 Jun; 270(25):15148-52. PubMed ID: 7541036
[TBL] [Abstract][Full Text] [Related]
12. Unusual clinical severity of complement membrane cofactor protein-associated hemolytic-uremic syndrome and uniparental isodisomy.
Fremeaux-Bacchi V; Sanlaville D; Menouer S; Blouin J; Dragon-Durey MA; Fischbach M; Vekemans M; Fridman WH
Am J Kidney Dis; 2007 Feb; 49(2):323-9. PubMed ID: 17261436
[TBL] [Abstract][Full Text] [Related]
13. Membrane cofactor protein: importance of N- and O-glycosylation for complement regulatory function.
Liszewski MK; Leung MK; Atkinson JP
J Immunol; 1998 Oct; 161(7):3711-8. PubMed ID: 9759896
[TBL] [Abstract][Full Text] [Related]
14. The molecular and structural bases for the association of complement C3 mutations with atypical hemolytic uremic syndrome.
Martínez-Barricarte R; Heurich M; López-Perrote A; Tortajada A; Pinto S; López-Trascasa M; Sánchez-Corral P; Morgan BP; Llorca O; Harris CL; Rodríguez de Córdoba S
Mol Immunol; 2015 Aug; 66(2):263-73. PubMed ID: 25879158
[TBL] [Abstract][Full Text] [Related]
15. Functional characterization of two novel non-synonymous alterations in CD46 and a Q950H change in factor H found in atypical hemolytic uremic syndrome patients.
Mohlin FC; Nilsson SC; Levart TK; Golubovic E; Rusai K; Müller-Sacherer T; Arbeiter K; Pállinger É; Szarvas N; Csuka D; Szilágyi Á; Villoutreix BO; Prohászka Z; Blom AM
Mol Immunol; 2015 Jun; 65(2):367-76. PubMed ID: 25733390
[TBL] [Abstract][Full Text] [Related]
16. Insights into hemolytic uremic syndrome: segregation of three independent predisposition factors in a large, multiple affected pedigree.
Esparza-Gordillo J; Jorge EG; Garrido CA; Carreras L; López-Trascasa M; Sánchez-Corral P; de Córdoba SR
Mol Immunol; 2006 Apr; 43(11):1769-75. PubMed ID: 16386793
[TBL] [Abstract][Full Text] [Related]
17. C4b-binding protein and a 60,000-Dalton plasma protein share antigenic determinants with membrane cofactor protein of complement.
Seya T; Nagasawa S; Atkinson JP
J Immunol; 1990 Mar; 144(6):2312-20. PubMed ID: 1690242
[TBL] [Abstract][Full Text] [Related]
18. Control of C3b and C5b deposition by CD46 (membrane cofactor protein) after alternative but not classical complement activation.
Devaux P; Christiansen D; Fontaine M; Gerlier D
Eur J Immunol; 1999 Mar; 29(3):815-22. PubMed ID: 10092084
[TBL] [Abstract][Full Text] [Related]
19. Molecular cloning of guinea pig membrane cofactor protein: preferential expression in testis.
Hosokawa M; Nonaka M; Okada N; Nonaka M; Okada H
J Immunol; 1996 Dec; 157(11):4946-52. PubMed ID: 8943400
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the promoter region of the membrane cofactor protein (CD46) gene of the human complement system and comparison to a membrane cofactor protein-like genetic element.
Cui W; Hourcade D; Post T; Greenlund AC; Atkinson JP; Kumar V
J Immunol; 1993 Oct; 151(8):4137-46. PubMed ID: 7691939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
